NCT05183035 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05183035
Title	Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	PedAL BCU, LLC
Indications	acute myeloid leukemia
Therapies	Azacitidine + Cytarabine + Fludarabine + Gemtuzumab ozogamicin + Venetoclax Azacitidine + Cytarabine + Fludarabine + Gemtuzumab ozogamicin
Age Groups:	child \| adult
Covered Countries	USA \| SWE \| NZL \| NOR \| NLD \| ITA \| ISR \| FRA \| FIN \| ESP \| DNK \| DEU \| CZE \| CHE \| CAN \| BEL \| AUT \| AUS

NCT05183035
Clinical Trial Detail